Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial.
Park CK, Jun HR, Oh HJ, Lee JY, Cho HJ, Kim YC, Lee JE, Yoon SH, Choi CM, Lee JC, Lee SY, Lee SY, Chun SM, Oh IJ.
Park CK, et al. Among authors: lee sy, lee jc, lee je, lee jy.
Cells. 2023 Apr 25;12(9):1246. doi: 10.3390/cells12091246.
Cells. 2023.
PMID: 37174645
Free PMC article.
Clinical Trial.